IN8bio, Inc. (INAB)
1.44
-0.01
(-0.69%)
USD |
NASDAQ |
Apr 17, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
IN8bio Total Liabilities (Quarterly) : 4.724M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | 5.26M |
| Calidi Biotherapeutics, Inc. | 5.098M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.28M |
| Shareholders Equity (Quarterly) | 27.56M |
| Debt to Equity Ratio | 0.101 |
| Current Ratio | 8.82 |
| Net Debt Paydown Yield | 5.06% |